mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |